JP2024541121A - イソプロピル－ｄ－グルコピラノシド誘導体、製造方法及びその用途 - Google Patents

イソプロピル－ｄ－グルコピラノシド誘導体、製造方法及びその用途 Download PDF

Info

Publication number
JP2024541121A
JP2024541121A JP2024547816A JP2024547816A JP2024541121A JP 2024541121 A JP2024541121 A JP 2024541121A JP 2024547816 A JP2024547816 A JP 2024547816A JP 2024547816 A JP2024547816 A JP 2024547816A JP 2024541121 A JP2024541121 A JP 2024541121A
Authority
JP
Japan
Prior art keywords
group
hydrogen
tritium
deuterium
chemical formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024547816A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024541121A5 (https=
Inventor
陳令儀
王翊
廖▲ぶん▼玲
李育棠
呂亭萱
黄郁文
李家維
王貞
陳方儀
焦伝金
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2024541121A publication Critical patent/JP2024541121A/ja
Publication of JP2024541121A5 publication Critical patent/JP2024541121A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Otolaryngology (AREA)
JP2024547816A 2021-10-25 2022-10-25 イソプロピル－ｄ－グルコピラノシド誘導体、製造方法及びその用途 Pending JP2024541121A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163271411P 2021-10-25 2021-10-25
US63/271,411 2021-10-25
PCT/CN2022/127414 WO2023072085A1 (zh) 2021-10-25 2022-10-25 异丙基-d-吡喃葡萄糖苷衍生物、制备方法及其用途

Publications (2)

Publication Number Publication Date
JP2024541121A true JP2024541121A (ja) 2024-11-06
JP2024541121A5 JP2024541121A5 (https=) 2025-10-28

Family

ID=86159046

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024547816A Pending JP2024541121A (ja) 2021-10-25 2022-10-25 イソプロピル－ｄ－グルコピラノシド誘導体、製造方法及びその用途
JP2024547815A Pending JP2024539499A (ja) 2021-10-25 2022-10-25 神経修復を促進するためのイソロイホリン及びその誘導体の用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024547815A Pending JP2024539499A (ja) 2021-10-25 2022-10-25 神経修復を促進するためのイソロイホリン及びその誘導体の用途

Country Status (7)

Country Link
US (2) US20250255893A1 (https=)
EP (2) EP4424695A4 (https=)
JP (2) JP2024541121A (https=)
KR (2) KR20240090983A (https=)
CN (2) CN118139869A (https=)
TW (2) TWI898161B (https=)
WO (2) WO2023072069A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101045072A (zh) * 2007-05-08 2007-10-03 胡军 山香圆叶提取物及其医药用途
CN102617658B (zh) * 2012-03-09 2014-08-20 中国烟草总公司郑州烟草研究院 β-紫罗兰醇-β-D-葡糖苷的制备方法及其在烟草加香中的应用
CN102617659A (zh) * 2012-03-09 2012-08-01 中国烟草总公司郑州烟草研究院 α-紫罗兰醇葡糖苷的合成方法及其在卷烟中的加香应用
CN106167508A (zh) * 2016-07-13 2016-11-30 上海应用技术学院 一种具有紫罗兰香味的葡萄糖苷化合物及其制备方法

Also Published As

Publication number Publication date
TW202317142A (zh) 2023-05-01
US20240415859A1 (en) 2024-12-19
CN118215669A (zh) 2024-06-18
KR20240090982A (ko) 2024-06-21
TWI898161B (zh) 2025-09-21
WO2023072085A1 (zh) 2023-05-04
EP4424694A1 (en) 2024-09-04
EP4424695A1 (en) 2024-09-04
EP4424694A4 (en) 2026-03-11
JP2024539499A (ja) 2024-10-28
EP4424695A4 (en) 2025-10-22
TW202320806A (zh) 2023-06-01
WO2023072069A1 (zh) 2023-05-04
CN118139869A (zh) 2024-06-04
US20250255893A1 (en) 2025-08-14
KR20240090983A (ko) 2024-06-21

Similar Documents

Publication Publication Date Title
JP6190536B2 (ja) 幹細胞由来のエキソソームを有効成分に含む脳室内出血治療用薬学的組成物
Zulazmi et al. The utilization of small non‐mammals in traumatic brain injury research: a systematic review
CA3097083A1 (en) Treatment of aging-associated disease with modulators of leukotriene a4 hydrolase
JP2024541121A (ja) イソプロピル－ｄ－グルコピラノシド誘導体、製造方法及びその用途
Shan et al. Activation of the hippocampal CA1 astrocyte Gq and Gi G protein-coupled receptors exerts a protective effect against attention deficit hyperactivity disorder
JP2002522487A (ja) 視力及び記憶障害に対するヘテロサイクリックエステル又はアミド
TW201137354A (en) Myelin basic protein luciferase (MBP-luci) bioimaging model
CN116672466A (zh) M1区神经元活性抑制剂在制备缺血性脑卒中防治药物中的应用
JP2024541121A5 (https=)
CN116008558B (zh) 细胞外基质弹性蛋白降解物在制备诊断或延缓神经退行性疾病的产品中的应用
CN108314737B (zh) 一种重组蛋白及其制备方法和应用
CN118766923A (zh) Bmx抑制剂在制备治疗眼底新生血管疾病的药物中的应用
JP2025503039A (ja) ８－メチル－８－アザビシクロ［３．２．１］オクタン－３－イル ３－ヒドロキシ－２－フェニルプロパノエートのエステル
JP2024539499A5 (https=)
CN114651787A (zh) 用于构建小鼠视神经特异性脱髓鞘模型的小鼠的构建方法及其应用
US20180289655A1 (en) Methods and Compositions for the Intravenous Administration of Fumarates for the Treatment of Neurological Diseases
CA3181833A1 (en) Use of semaphorin-4d binding molecules for the treatment of rett syndrome
US20180338996A1 (en) Combination therapy for traumatic brain injury
Heng Vision Restoration in a Newly Characterized Porcine Model of Traumatic Optic Neuropathy
Hwang et al. Stem cells ameliorate neurotrauma-induced visual disturbances and retinopathy via broad normalization of the β-catenin-related signaling pathway
Zhu Research progress on brain-derived neurotrophic factor in ocular diseases
CN111617234B (zh) 外源性重组蛋白Reelin在制备治疗脑出血药物中的应用
Lu et al. In vivo neuronal visualization for ocular disease models through a novel NIR-II neurotracer
CN108250271B (zh) 一种蛙皮素、包含该蛙皮素的药物及其应用
WO2024243339A2 (en) Boldine to reduce muscle atrophy and promote neuromuscular recovery

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20250825

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20250825

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251020

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251017

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20260422